 Robert Ryu
Concepts (498)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vena Cava Filters | 24 | 2023 | 60 | 6.490 |
Why?
| | Embolization, Therapeutic | 44 | 2020 | 232 | 3.320 |
Why?
| | Liver Neoplasms | 60 | 2014 | 762 | 3.220 |
Why?
| | Device Removal | 18 | 2023 | 135 | 3.190 |
Why?
| | Yttrium Radioisotopes | 40 | 2020 | 53 | 2.880 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 10 | 2021 | 43 | 2.820 |
Why?
| | Carcinoma, Hepatocellular | 41 | 2014 | 359 | 2.540 |
Why?
| | Radiology, Interventional | 6 | 2024 | 32 | 2.490 |
Why?
| | Pulmonary Embolism | 11 | 2021 | 233 | 1.860 |
Why?
| | Radiography, Interventional | 17 | 2016 | 115 | 1.650 |
Why?
| | Esophageal and Gastric Varices | 4 | 2021 | 39 | 1.520 |
Why?
| | Chemoembolization, Therapeutic | 21 | 2014 | 87 | 1.490 |
Why?
| | Hypertension, Portal | 5 | 2016 | 66 | 1.310 |
Why?
| | Radiopharmaceuticals | 19 | 2020 | 174 | 1.300 |
Why?
| | Lumbar Vertebrae | 4 | 2021 | 246 | 1.240 |
Why?
| | Uterine Neoplasms | 11 | 2010 | 114 | 1.110 |
Why?
| | Vena Cava, Inferior | 7 | 2021 | 69 | 1.040 |
Why?
| | Educational Measurement | 2 | 2020 | 289 | 1.030 |
Why?
| | Venous Thrombosis | 6 | 2023 | 188 | 0.980 |
Why?
| | Lasers, Excimer | 2 | 2022 | 29 | 0.940 |
Why?
| | Renal Dialysis | 2 | 2020 | 434 | 0.920 |
Why?
| | Treatment Outcome | 71 | 2023 | 10813 | 0.920 |
Why?
| | Practice Patterns, Physicians' | 9 | 2021 | 1299 | 0.900 |
Why?
| | Portal Vein | 4 | 2016 | 118 | 0.890 |
Why?
| | Microspheres | 29 | 2013 | 134 | 0.880 |
Why?
| | Prosthesis Design | 7 | 2020 | 330 | 0.840 |
Why?
| | Magnetic Resonance Imaging, Interventional | 8 | 2014 | 24 | 0.810 |
Why?
| | Specialty Boards | 2 | 2020 | 36 | 0.800 |
Why?
| | Postoperative Complications | 8 | 2021 | 2665 | 0.790 |
Why?
| | Total Disc Replacement | 2 | 2020 | 14 | 0.780 |
Why?
| | Leiomyoma | 9 | 2007 | 79 | 0.770 |
Why?
| | Intervertebral Disc | 3 | 2020 | 37 | 0.760 |
Why?
| | Uterus | 7 | 2007 | 213 | 0.760 |
Why?
| | Forecasting | 1 | 2024 | 383 | 0.740 |
Why?
| | End Stage Liver Disease | 2 | 2021 | 81 | 0.740 |
Why?
| | Venous Insufficiency | 3 | 2007 | 12 | 0.710 |
Why?
| | Saphenous Vein | 3 | 2007 | 36 | 0.700 |
Why?
| | Thromboembolism | 3 | 2017 | 117 | 0.690 |
Why?
| | Middle Aged | 86 | 2023 | 33441 | 0.660 |
Why?
| | Medicare | 3 | 2020 | 777 | 0.650 |
Why?
| | Spinal Fusion | 3 | 2021 | 252 | 0.650 |
Why?
| | Humans | 151 | 2024 | 137601 | 0.650 |
Why?
| | Prosthesis Implantation | 3 | 2017 | 152 | 0.630 |
Why?
| | Diagnostic Imaging | 4 | 2024 | 323 | 0.630 |
Why?
| | Laser Therapy | 3 | 2007 | 128 | 0.630 |
Why?
| | Intervertebral Disc Displacement | 1 | 2020 | 40 | 0.620 |
Why?
| | Cerebrospinal Fluid Leak | 1 | 2020 | 62 | 0.600 |
Why?
| | Endovascular Procedures | 5 | 2020 | 340 | 0.590 |
Why?
| | Graft Occlusion, Vascular | 2 | 2018 | 39 | 0.590 |
Why?
| | Magnetic Resonance Angiography | 10 | 2014 | 239 | 0.590 |
Why?
| | Medicine | 1 | 2020 | 126 | 0.580 |
Why?
| | Low Back Pain | 1 | 2020 | 106 | 0.570 |
Why?
| | Venous Thromboembolism | 4 | 2017 | 319 | 0.560 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2018 | 18 | 0.560 |
Why?
| | Ultrasonography, Interventional | 3 | 2016 | 139 | 0.550 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 3 | 2019 | 210 | 0.540 |
Why?
| | Spine | 1 | 2019 | 175 | 0.540 |
Why?
| | Magnetic Resonance Imaging | 27 | 2023 | 3607 | 0.530 |
Why?
| | Female | 102 | 2023 | 73359 | 0.530 |
Why?
| | Time Factors | 25 | 2021 | 6818 | 0.530 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2017 | 58 | 0.530 |
Why?
| | Ascites | 2 | 2016 | 48 | 0.520 |
Why?
| | Gastrointestinal Hemorrhage | 4 | 2021 | 134 | 0.520 |
Why?
| | Retrospective Studies | 37 | 2023 | 15720 | 0.500 |
Why?
| | Stents | 8 | 2015 | 523 | 0.500 |
Why?
| | Aged | 63 | 2021 | 23938 | 0.500 |
Why?
| | Orthopedic Procedures | 1 | 2019 | 222 | 0.500 |
Why?
| | Tomography, X-Ray Computed | 24 | 2018 | 2679 | 0.480 |
Why?
| | Aged, 80 and over | 34 | 2021 | 7609 | 0.480 |
Why?
| | Digestive System Neoplasms | 1 | 2015 | 8 | 0.480 |
Why?
| | Intervertebral Disc Degeneration | 1 | 2016 | 33 | 0.470 |
Why?
| | Brachytherapy | 8 | 2008 | 127 | 0.470 |
Why?
| | Male | 87 | 2023 | 67690 | 0.470 |
Why?
| | Adult | 59 | 2021 | 37910 | 0.460 |
Why?
| | Cholestasis | 2 | 2015 | 210 | 0.460 |
Why?
| | Social Media | 1 | 2017 | 159 | 0.440 |
Why?
| | United States | 16 | 2024 | 14925 | 0.430 |
Why?
| | Radiology | 2 | 2024 | 177 | 0.420 |
Why?
| | Radiation Dosage | 6 | 2020 | 188 | 0.410 |
Why?
| | Thrombosis | 4 | 2022 | 373 | 0.390 |
Why?
| | Clinical Competence | 2 | 2019 | 1122 | 0.390 |
Why?
| | Liver Neoplasms, Experimental | 4 | 2020 | 26 | 0.390 |
Why?
| | Ovary | 3 | 2003 | 223 | 0.370 |
Why?
| | Imaging, Three-Dimensional | 5 | 2011 | 564 | 0.360 |
Why?
| | Angiography | 11 | 2011 | 209 | 0.360 |
Why?
| | Liver Cirrhosis | 6 | 2019 | 312 | 0.340 |
Why?
| | Risk Factors | 18 | 2020 | 10319 | 0.340 |
Why?
| | Uterine Artery Embolization | 1 | 2010 | 7 | 0.330 |
Why?
| | Vascular System Injuries | 3 | 2016 | 73 | 0.330 |
Why?
| | Cholangiocarcinoma | 4 | 2013 | 96 | 0.330 |
Why?
| | Perfusion Imaging | 1 | 2010 | 60 | 0.320 |
Why?
| | Drainage | 3 | 2019 | 173 | 0.320 |
Why?
| | Endoscopy, Gastrointestinal | 3 | 2021 | 229 | 0.320 |
Why?
| | Angioplasty | 3 | 2007 | 47 | 0.320 |
Why?
| | Adenoma, Islet Cell | 1 | 2009 | 6 | 0.320 |
Why?
| | Chicago | 6 | 2017 | 63 | 0.320 |
Why?
| | Aortic Aneurysm, Abdominal | 3 | 2007 | 158 | 0.320 |
Why?
| | Liver Abscess | 1 | 2009 | 6 | 0.310 |
Why?
| | Predictive Value of Tests | 11 | 2020 | 2017 | 0.310 |
Why?
| | Thyroid Gland | 1 | 2009 | 91 | 0.310 |
Why?
| | Observer Variation | 3 | 2010 | 349 | 0.310 |
Why?
| | Polyvinyl Alcohol | 3 | 2005 | 18 | 0.300 |
Why?
| | Neoplasms | 5 | 2023 | 2691 | 0.300 |
Why?
| | Hepatic Veins | 1 | 2008 | 34 | 0.290 |
Why?
| | Phlebography | 6 | 2015 | 37 | 0.290 |
Why?
| | Rabbits | 12 | 2020 | 765 | 0.290 |
Why?
| | Contrast Media | 12 | 2016 | 469 | 0.290 |
Why?
| | Gelatin | 2 | 2005 | 52 | 0.280 |
Why?
| | Portography | 4 | 2016 | 12 | 0.280 |
Why?
| | Neovascularization, Pathologic | 5 | 2009 | 296 | 0.280 |
Why?
| | Lymphangioma, Cystic | 1 | 2007 | 5 | 0.270 |
Why?
| | Databases, Factual | 7 | 2020 | 1382 | 0.270 |
Why?
| | Patient Selection | 6 | 2020 | 687 | 0.270 |
Why?
| | Pancreatic Neoplasms | 3 | 2010 | 853 | 0.270 |
Why?
| | Liver Transplantation | 5 | 2015 | 843 | 0.270 |
Why?
| | Prosthesis Failure | 3 | 2017 | 123 | 0.270 |
Why?
| | Catheterization | 7 | 2013 | 177 | 0.260 |
Why?
| | Aortography | 1 | 2007 | 53 | 0.260 |
Why?
| | Antineoplastic Agents | 6 | 2014 | 2128 | 0.260 |
Why?
| | Logistic Models | 8 | 2021 | 2076 | 0.260 |
Why?
| | Hepatic Artery | 5 | 2010 | 56 | 0.260 |
Why?
| | Referral and Consultation | 1 | 2012 | 794 | 0.250 |
Why?
| | Thrombolytic Therapy | 4 | 2023 | 148 | 0.250 |
Why?
| | Bile Duct Neoplasms | 4 | 2013 | 118 | 0.250 |
Why?
| | Linear Models | 4 | 2017 | 848 | 0.250 |
Why?
| | Thyroid Neoplasms | 1 | 2009 | 324 | 0.240 |
Why?
| | Acrylic Resins | 1 | 2005 | 46 | 0.240 |
Why?
| | Radiation Injuries | 5 | 2010 | 147 | 0.230 |
Why?
| | Blood Vessel Prosthesis Implantation | 2 | 2007 | 216 | 0.230 |
Why?
| | Blister | 1 | 2004 | 39 | 0.220 |
Why?
| | Arteries | 7 | 2013 | 261 | 0.210 |
Why?
| | Internship and Residency | 2 | 2019 | 1172 | 0.210 |
Why?
| | Multivariate Analysis | 7 | 2017 | 1488 | 0.210 |
Why?
| | Survival Rate | 12 | 2018 | 1906 | 0.210 |
Why?
| | Cohort Studies | 7 | 2023 | 5691 | 0.210 |
Why?
| | Postphlebitic Syndrome | 1 | 2023 | 2 | 0.200 |
Why?
| | Postthrombotic Syndrome | 1 | 2023 | 13 | 0.200 |
Why?
| | Jugular Veins | 3 | 1997 | 42 | 0.200 |
Why?
| | Neoplasm Staging | 8 | 2014 | 1359 | 0.190 |
Why?
| | Fluoroscopy | 2 | 2016 | 158 | 0.190 |
Why?
| | Prospective Studies | 16 | 2023 | 7580 | 0.190 |
Why?
| | Elasticity Imaging Techniques | 1 | 2022 | 59 | 0.190 |
Why?
| | Catheters | 3 | 2023 | 72 | 0.190 |
Why?
| | Education, Medical, Continuing | 2 | 2017 | 128 | 0.190 |
Why?
| | Clinical Trials as Topic | 3 | 2013 | 1029 | 0.180 |
Why?
| | Neoplasms, Experimental | 2 | 2013 | 174 | 0.180 |
Why?
| | Kaplan-Meier Estimate | 9 | 2015 | 887 | 0.180 |
Why?
| | Chi-Square Distribution | 6 | 2014 | 520 | 0.180 |
Why?
| | Disease Progression | 14 | 2014 | 2722 | 0.180 |
Why?
| | Multicenter Studies as Topic | 1 | 2022 | 306 | 0.180 |
Why?
| | Constriction, Pathologic | 3 | 2019 | 238 | 0.180 |
Why?
| | Liver | 7 | 2013 | 1872 | 0.180 |
Why?
| | Vascular Patency | 3 | 2018 | 109 | 0.170 |
Why?
| | Bone-Implant Interface | 1 | 2021 | 3 | 0.170 |
Why?
| | Angiography, Digital Subtraction | 6 | 2014 | 45 | 0.170 |
Why?
| | Reoperation | 4 | 2019 | 579 | 0.170 |
Why?
| | Ultrasonography, Doppler, Color | 3 | 2008 | 39 | 0.170 |
Why?
| | alpha-Fetoproteins | 2 | 2012 | 41 | 0.170 |
Why?
| | Catheter Ablation | 1 | 2004 | 330 | 0.170 |
Why?
| | Surgical Stomas | 1 | 2000 | 7 | 0.170 |
Why?
| | Medical Oncology | 2 | 2013 | 301 | 0.170 |
Why?
| | Adolescent | 16 | 2021 | 21435 | 0.170 |
Why?
| | Disease Models, Animal | 6 | 2016 | 4301 | 0.170 |
Why?
| | Liver Diseases | 2 | 2007 | 301 | 0.170 |
Why?
| | Colostomy | 1 | 2000 | 28 | 0.170 |
Why?
| | Varicose Veins | 1 | 2000 | 17 | 0.170 |
Why?
| | Infusions, Intra-Arterial | 9 | 2010 | 60 | 0.160 |
Why?
| | Sensitivity and Specificity | 9 | 2012 | 1941 | 0.160 |
Why?
| | Positron Emission Tomography Computed Tomography | 1 | 2020 | 100 | 0.160 |
Why?
| | Costs and Cost Analysis | 1 | 2020 | 212 | 0.160 |
Why?
| | Hepatorenal Syndrome | 1 | 2019 | 13 | 0.160 |
Why?
| | Lumbosacral Region | 1 | 2020 | 60 | 0.160 |
Why?
| | Budd-Chiari Syndrome | 1 | 1999 | 5 | 0.160 |
Why?
| | Hemorrhage | 2 | 2023 | 719 | 0.160 |
Why?
| | Laminoplasty | 1 | 2019 | 2 | 0.150 |
Why?
| | Follow-Up Studies | 11 | 2013 | 5121 | 0.150 |
Why?
| | Laminectomy | 1 | 2019 | 32 | 0.150 |
Why?
| | Image Interpretation, Computer-Assisted | 3 | 2011 | 264 | 0.150 |
Why?
| | Robotic Surgical Procedures | 1 | 2021 | 138 | 0.150 |
Why?
| | Bile Ducts | 1 | 2019 | 68 | 0.150 |
Why?
| | Ohio | 1 | 2019 | 136 | 0.150 |
Why?
| | Iliac Artery | 2 | 2018 | 54 | 0.150 |
Why?
| | Specialization | 1 | 2020 | 148 | 0.150 |
Why?
| | Glass | 3 | 2013 | 44 | 0.150 |
Why?
| | Young Adult | 8 | 2021 | 13203 | 0.150 |
Why?
| | Survival Analysis | 6 | 2011 | 1289 | 0.150 |
Why?
| | Models, Educational | 1 | 2019 | 93 | 0.150 |
Why?
| | Biliary Fistula | 1 | 1998 | 4 | 0.140 |
Why?
| | Urinary Fistula | 1 | 1998 | 9 | 0.140 |
Why?
| | Diffusion Magnetic Resonance Imaging | 2 | 2010 | 154 | 0.140 |
Why?
| | Intestine, Small | 1 | 2019 | 155 | 0.140 |
Why?
| | Mesenteric Veins | 1 | 1998 | 22 | 0.140 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 248 | 0.140 |
Why?
| | Pain | 1 | 2003 | 759 | 0.140 |
Why?
| | Fibrin | 2 | 2023 | 86 | 0.140 |
Why?
| | Writing | 1 | 2019 | 99 | 0.140 |
Why?
| | Thrombectomy | 1 | 1998 | 73 | 0.140 |
Why?
| | United States Food and Drug Administration | 2 | 2017 | 200 | 0.130 |
Why?
| | Liver Circulation | 4 | 2015 | 19 | 0.130 |
Why?
| | Radiography | 7 | 2012 | 844 | 0.130 |
Why?
| | Treatment Failure | 4 | 2017 | 346 | 0.130 |
Why?
| | Patient Advocacy | 1 | 2017 | 76 | 0.130 |
Why?
| | Drug Utilization | 1 | 2017 | 168 | 0.130 |
Why?
| | Hemostasis, Surgical | 1 | 2016 | 22 | 0.130 |
Why?
| | Vena Cava, Superior | 1 | 2016 | 22 | 0.130 |
Why?
| | Severity of Illness Index | 2 | 2021 | 2840 | 0.120 |
Why?
| | Portal Pressure | 1 | 2016 | 4 | 0.120 |
Why?
| | History, 20th Century | 1 | 2017 | 325 | 0.120 |
Why?
| | Hospitals | 1 | 2021 | 691 | 0.120 |
Why?
| | Academic Medical Centers | 1 | 2019 | 506 | 0.120 |
Why?
| | Anatomic Landmarks | 1 | 2016 | 29 | 0.120 |
Why?
| | Balloon Occlusion | 1 | 2016 | 34 | 0.120 |
Why?
| | Finite Element Analysis | 1 | 2016 | 75 | 0.120 |
Why?
| | Gadolinium DTPA | 5 | 2014 | 70 | 0.120 |
Why?
| | Research Design | 3 | 2013 | 1110 | 0.120 |
Why?
| | Doxorubicin | 3 | 2013 | 338 | 0.120 |
Why?
| | Cell Line, Tumor | 7 | 2013 | 3400 | 0.120 |
Why?
| | Lower Extremity | 1 | 2020 | 435 | 0.120 |
Why?
| | Patient Readmission | 1 | 2021 | 701 | 0.120 |
Why?
| | Stomach | 2 | 2013 | 108 | 0.120 |
Why?
| | Reproducibility of Results | 8 | 2011 | 3287 | 0.120 |
Why?
| | Models, Anatomic | 1 | 2016 | 84 | 0.120 |
Why?
| | Operative Time | 1 | 2016 | 146 | 0.120 |
Why?
| | Aorta | 1 | 2018 | 414 | 0.120 |
Why?
| | Radiation Exposure | 1 | 2016 | 54 | 0.120 |
Why?
| | Wounds, Nonpenetrating | 4 | 2000 | 286 | 0.120 |
Why?
| | Bile Ducts, Intrahepatic | 3 | 2013 | 64 | 0.120 |
Why?
| | Intraoperative Complications | 1 | 2016 | 138 | 0.110 |
Why?
| | Hospital Mortality | 2 | 2018 | 911 | 0.110 |
Why?
| | Necrosis | 5 | 2020 | 247 | 0.110 |
Why?
| | Dilatation | 1 | 2015 | 67 | 0.110 |
Why?
| | Sex Factors | 2 | 2018 | 2046 | 0.110 |
Why?
| | Biopsy | 3 | 2014 | 1089 | 0.110 |
Why?
| | Carotid Artery Injuries | 3 | 2000 | 39 | 0.110 |
Why?
| | Education, Medical, Graduate | 1 | 2019 | 484 | 0.110 |
Why?
| | Wounds, Gunshot | 1 | 1998 | 225 | 0.110 |
Why?
| | Cisplatin | 3 | 2012 | 325 | 0.110 |
Why?
| | Data Interpretation, Statistical | 3 | 2013 | 360 | 0.110 |
Why?
| | Foreign-Body Migration | 1 | 2014 | 33 | 0.110 |
Why?
| | Length of Stay | 2 | 2019 | 1210 | 0.110 |
Why?
| | Carbon Dioxide | 1 | 2016 | 239 | 0.110 |
Why?
| | Kidney Diseases | 1 | 1998 | 407 | 0.100 |
Why?
| | Stress, Mechanical | 1 | 2016 | 483 | 0.100 |
Why?
| | Magnetite Nanoparticles | 1 | 2013 | 28 | 0.100 |
Why?
| | Anticoagulants | 2 | 2017 | 660 | 0.100 |
Why?
| | Duodenum | 1 | 2013 | 76 | 0.100 |
Why?
| | Ultrasonography | 3 | 2022 | 762 | 0.100 |
Why?
| | Peripheral Arterial Disease | 1 | 2020 | 483 | 0.100 |
Why?
| | Arthroscopy | 3 | 1992 | 234 | 0.100 |
Why?
| | Longitudinal Studies | 1 | 2020 | 2836 | 0.100 |
Why?
| | Prevalence | 3 | 2021 | 2735 | 0.100 |
Why?
| | Catheterization, Peripheral | 3 | 2008 | 108 | 0.100 |
Why?
| | Regional Blood Flow | 3 | 2007 | 490 | 0.100 |
Why?
| | Patient Education as Topic | 1 | 2017 | 761 | 0.100 |
Why?
| | Biomechanical Phenomena | 1 | 2016 | 814 | 0.100 |
Why?
| | Proportional Hazards Models | 5 | 2014 | 1272 | 0.100 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2014 | 1706 | 0.090 |
Why?
| | Shoulder Injuries | 1 | 1992 | 60 | 0.090 |
Why?
| | Acromion | 1 | 1992 | 8 | 0.090 |
Why?
| | Electroporation | 1 | 2012 | 38 | 0.090 |
Why?
| | Tendon Injuries | 1 | 1992 | 67 | 0.090 |
Why?
| | Respiratory-Gated Imaging Techniques | 1 | 2011 | 9 | 0.090 |
Why?
| | Fibromuscular Dysplasia | 1 | 2011 | 8 | 0.090 |
Why?
| | Rotator Cuff | 1 | 1992 | 47 | 0.090 |
Why?
| | Animals | 15 | 2021 | 37088 | 0.090 |
Why?
| | Prognosis | 5 | 2010 | 3966 | 0.090 |
Why?
| | Comorbidity | 1 | 2016 | 1634 | 0.090 |
Why?
| | Yttrium | 1 | 2010 | 4 | 0.080 |
Why?
| | Surgery, Computer-Assisted | 1 | 2011 | 72 | 0.080 |
Why?
| | Research Report | 1 | 2011 | 82 | 0.080 |
Why?
| | Injections, Intra-Arterial | 5 | 2012 | 27 | 0.080 |
Why?
| | Tumor Burden | 3 | 2020 | 306 | 0.080 |
Why?
| | Neuroendocrine Tumors | 1 | 2011 | 108 | 0.080 |
Why?
| | Practice Guidelines as Topic | 5 | 2013 | 1541 | 0.080 |
Why?
| | Punctures | 1 | 2010 | 38 | 0.080 |
Why?
| | Biomarkers, Tumor | 3 | 2012 | 1233 | 0.080 |
Why?
| | Decision Support Techniques | 1 | 2014 | 422 | 0.080 |
Why?
| | Biopsy, Fine-Needle | 1 | 2009 | 68 | 0.080 |
Why?
| | Gastrostomy | 2 | 2009 | 117 | 0.080 |
Why?
| | Recurrence | 3 | 2021 | 1073 | 0.080 |
Why?
| | Pancreatic Pseudocyst | 1 | 2009 | 17 | 0.080 |
Why?
| | Bilirubin | 3 | 2010 | 89 | 0.080 |
Why?
| | Breast Neoplasms | 2 | 2014 | 2270 | 0.070 |
Why?
| | Liver Function Tests | 3 | 2015 | 106 | 0.070 |
Why?
| | Radiation Pneumonitis | 1 | 2008 | 31 | 0.070 |
Why?
| | Ambulatory Care Facilities | 1 | 2010 | 243 | 0.070 |
Why?
| | Biliary Tract | 1 | 2008 | 14 | 0.070 |
Why?
| | Radiotherapy Dosage | 4 | 2010 | 278 | 0.070 |
Why?
| | Knee Injuries | 1 | 1989 | 103 | 0.070 |
Why?
| | Maximum Allowable Concentration | 1 | 2007 | 16 | 0.070 |
Why?
| | Palliative Care | 1 | 2015 | 813 | 0.070 |
Why?
| | Subtraction Technique | 1 | 2007 | 24 | 0.070 |
Why?
| | Neoplasm Transplantation | 1 | 2008 | 250 | 0.070 |
Why?
| | Diagnosis, Differential | 3 | 2009 | 1488 | 0.070 |
Why?
| | Endpoint Determination | 3 | 2013 | 76 | 0.070 |
Why?
| | Vacuum Curettage | 1 | 2007 | 5 | 0.070 |
Why?
| | Diagnostic Errors | 1 | 2008 | 171 | 0.070 |
Why?
| | Acute Disease | 2 | 2021 | 1005 | 0.070 |
Why?
| | Ultrasonography, Doppler, Duplex | 2 | 2004 | 42 | 0.070 |
Why?
| | Incidence | 3 | 2009 | 2805 | 0.070 |
Why?
| | Image Enhancement | 4 | 2011 | 189 | 0.070 |
Why?
| | Radiotherapy | 1 | 2008 | 206 | 0.060 |
Why?
| | Leiomyomatosis | 1 | 2006 | 6 | 0.060 |
Why?
| | Catheterization, Central Venous | 2 | 1999 | 113 | 0.060 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 274 | 0.060 |
Why?
| | Credentialing | 1 | 2006 | 19 | 0.060 |
Why?
| | Quality Assurance, Health Care | 1 | 2008 | 326 | 0.060 |
Why?
| | Iron | 1 | 2008 | 323 | 0.060 |
Why?
| | Fluorescent Dyes | 1 | 2007 | 318 | 0.060 |
Why?
| | Ethics, Research | 1 | 2005 | 35 | 0.060 |
Why?
| | Personnel Selection | 1 | 2006 | 81 | 0.060 |
Why?
| | Hospitalization | 3 | 2021 | 2197 | 0.060 |
Why?
| | Knee Joint | 1 | 1989 | 408 | 0.060 |
Why?
| | Heart Failure | 1 | 2018 | 2048 | 0.060 |
Why?
| | Organ Size | 3 | 2013 | 472 | 0.060 |
Why?
| | Decision Making | 1 | 2012 | 937 | 0.060 |
Why?
| | Postmenopause | 1 | 2007 | 373 | 0.060 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 2 | 2020 | 109 | 0.060 |
Why?
| | Kidney Transplantation | 1 | 2011 | 701 | 0.060 |
Why?
| | Combined Modality Therapy | 2 | 2017 | 1226 | 0.060 |
Why?
| | Odds Ratio | 2 | 2017 | 1074 | 0.050 |
Why?
| | Dose-Response Relationship, Radiation | 3 | 2008 | 143 | 0.050 |
Why?
| | Analgesia, Patient-Controlled | 1 | 2003 | 13 | 0.050 |
Why?
| | Pilot Projects | 4 | 2009 | 1742 | 0.050 |
Why?
| | Ischemia | 1 | 2006 | 408 | 0.050 |
Why?
| | Iliac Vein | 1 | 2023 | 13 | 0.050 |
Why?
| | Fellowships and Scholarships | 1 | 2006 | 302 | 0.050 |
Why?
| | Illinois | 3 | 2009 | 45 | 0.050 |
Why?
| | Femoral Vein | 1 | 2023 | 34 | 0.050 |
Why?
| | Watchful Waiting | 1 | 2023 | 76 | 0.050 |
Why?
| | Menisci, Tibial | 2 | 1995 | 61 | 0.050 |
Why?
| | Aneurysm, False | 2 | 2000 | 45 | 0.050 |
Why?
| | Elasticity | 1 | 2022 | 194 | 0.050 |
Why?
| | Pelvis | 1 | 2002 | 107 | 0.050 |
Why?
| | Drug Stability | 2 | 2013 | 161 | 0.040 |
Why?
| | Hepatectomy | 2 | 2013 | 236 | 0.040 |
Why?
| | Colorectal Neoplasms | 1 | 2009 | 801 | 0.040 |
Why?
| | Feasibility Studies | 3 | 2011 | 964 | 0.040 |
Why?
| | Confidence Intervals | 2 | 2013 | 334 | 0.040 |
Why?
| | World Health Organization | 2 | 2012 | 126 | 0.040 |
Why?
| | X-Ray Microtomography | 1 | 2021 | 97 | 0.040 |
Why?
| | Osseointegration | 1 | 2021 | 71 | 0.040 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2021 | 60 | 0.040 |
Why?
| | Allografts | 1 | 2021 | 145 | 0.040 |
Why?
| | Europe | 2 | 2012 | 403 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2023 | 610 | 0.040 |
Why?
| | Administrative Claims, Healthcare | 1 | 2020 | 26 | 0.040 |
Why?
| | Mice, SCID | 1 | 2021 | 368 | 0.040 |
Why?
| | Carotid Artery, Internal | 1 | 2000 | 44 | 0.040 |
Why?
| | Neural Crest | 1 | 2021 | 121 | 0.040 |
Why?
| | Cardiologists | 1 | 2020 | 45 | 0.040 |
Why?
| | Radiologists | 1 | 2020 | 49 | 0.040 |
Why?
| | Disease-Free Survival | 2 | 2013 | 672 | 0.040 |
Why?
| | Skull | 1 | 2021 | 145 | 0.040 |
Why?
| | Bone Marrow Cells | 1 | 2021 | 322 | 0.040 |
Why?
| | Hepatic Encephalopathy | 1 | 1999 | 21 | 0.040 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2020 | 65 | 0.040 |
Why?
| | Menstrual Cycle | 1 | 2000 | 133 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2021 | 596 | 0.040 |
Why?
| | Evidence-Based Medicine | 2 | 2013 | 739 | 0.040 |
Why?
| | Tomography, Emission-Computed | 2 | 2009 | 67 | 0.040 |
Why?
| | Tracheoesophageal Fistula | 1 | 1999 | 33 | 0.040 |
Why?
| | Anastomosis, Surgical | 1 | 2019 | 155 | 0.040 |
Why?
| | Liver Failure | 1 | 1999 | 86 | 0.040 |
Why?
| | Multiple Organ Failure | 1 | 1999 | 123 | 0.040 |
Why?
| | Streptokinase | 1 | 1998 | 10 | 0.040 |
Why?
| | Equipment Design | 2 | 2012 | 509 | 0.040 |
Why?
| | Serum Albumin | 1 | 1999 | 150 | 0.040 |
Why?
| | Analysis of Variance | 2 | 2011 | 1307 | 0.040 |
Why?
| | Postoperative Hemorrhage | 1 | 1999 | 85 | 0.040 |
Why?
| | Ethiodized Oil | 2 | 2008 | 8 | 0.040 |
Why?
| | Mitomycin | 2 | 2008 | 35 | 0.040 |
Why?
| | Swine | 2 | 2016 | 795 | 0.040 |
Why?
| | Guidelines as Topic | 2 | 2010 | 270 | 0.040 |
Why?
| | Population Surveillance | 1 | 2001 | 479 | 0.040 |
Why?
| | Nervous System Diseases | 2 | 2017 | 272 | 0.030 |
Why?
| | Cartilage Diseases | 2 | 1995 | 45 | 0.030 |
Why?
| | Cause of Death | 1 | 1999 | 424 | 0.030 |
Why?
| | Intracranial Hypertension | 1 | 1997 | 42 | 0.030 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 1997 | 128 | 0.030 |
Why?
| | Radiography, Thoracic | 1 | 1997 | 167 | 0.030 |
Why?
| | Abdominal Injuries | 1 | 1998 | 120 | 0.030 |
Why?
| | Demography | 1 | 2017 | 294 | 0.030 |
Why?
| | Tuberculosis, Pulmonary | 1 | 1997 | 142 | 0.030 |
Why?
| | Positron-Emission Tomography | 2 | 2008 | 295 | 0.030 |
Why?
| | Recovery of Function | 1 | 2000 | 664 | 0.030 |
Why?
| | Databases as Topic | 2 | 2010 | 69 | 0.030 |
Why?
| | Surgeons | 1 | 2020 | 306 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2003 | 3550 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2020 | 571 | 0.030 |
Why?
| | Fibrinolytic Agents | 1 | 1998 | 275 | 0.030 |
Why?
| | Lung | 1 | 2008 | 4057 | 0.030 |
Why?
| | Inpatients | 1 | 2019 | 493 | 0.030 |
Why?
| | Models, Cardiovascular | 1 | 2016 | 195 | 0.030 |
Why?
| | Phantoms, Imaging | 2 | 2008 | 145 | 0.030 |
Why?
| | Cysts | 1 | 1995 | 115 | 0.030 |
Why?
| | Hospitals, Pediatric | 1 | 2017 | 516 | 0.030 |
Why?
| | Embolism | 2 | 2008 | 43 | 0.030 |
Why?
| | Preoperative Care | 1 | 2016 | 354 | 0.030 |
Why?
| | Ablation Techniques | 1 | 2013 | 33 | 0.030 |
Why?
| | Vascular Surgical Procedures | 1 | 2016 | 310 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2021 | 1999 | 0.020 |
Why?
| | Eligibility Determination | 1 | 2013 | 70 | 0.020 |
Why?
| | Scapula | 1 | 1992 | 44 | 0.020 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2013 | 215 | 0.020 |
Why?
| | Nausea | 1 | 2011 | 111 | 0.020 |
Why?
| | Muscular Diseases | 1 | 1992 | 112 | 0.020 |
Why?
| | Vomiting | 1 | 2011 | 131 | 0.020 |
Why?
| | Biomarkers | 2 | 2014 | 4092 | 0.020 |
Why?
| | International Agencies | 1 | 2010 | 34 | 0.020 |
Why?
| | Clinical Trials, Phase II as Topic | 1 | 2010 | 71 | 0.020 |
Why?
| | Diarrhea | 1 | 2011 | 183 | 0.020 |
Why?
| | Abdominal Pain | 1 | 2011 | 146 | 0.020 |
Why?
| | Neoadjuvant Therapy | 1 | 2013 | 407 | 0.020 |
Why?
| | Standard of Care | 1 | 2010 | 74 | 0.020 |
Why?
| | Risk Assessment | 2 | 2009 | 3438 | 0.020 |
Why?
| | Yttrium Isotopes | 1 | 2009 | 1 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5507 | 0.020 |
Why?
| | Registries | 1 | 2018 | 2043 | 0.020 |
Why?
| | Alkaline Phosphatase | 1 | 2010 | 151 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2010 | 320 | 0.020 |
Why?
| | Fatigue | 1 | 2011 | 336 | 0.020 |
Why?
| | Age Factors | 1 | 2017 | 3253 | 0.020 |
Why?
| | Chronic Disease | 1 | 2015 | 1788 | 0.020 |
Why?
| | Range of Motion, Articular | 1 | 1992 | 407 | 0.020 |
Why?
| | Terminology as Topic | 1 | 2011 | 245 | 0.020 |
Why?
| | Fibula | 1 | 1989 | 41 | 0.020 |
Why?
| | Ligaments, Articular | 1 | 1989 | 52 | 0.020 |
Why?
| | ROC Curve | 1 | 2010 | 562 | 0.020 |
Why?
| | Rhenium | 1 | 2008 | 4 | 0.020 |
Why?
| | Radioisotopes | 1 | 2008 | 31 | 0.020 |
Why?
| | Iohexol | 1 | 2008 | 22 | 0.020 |
Why?
| | Body Burden | 1 | 2007 | 8 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2008 | 320 | 0.020 |
Why?
| | Hysterosalpingography | 1 | 2007 | 6 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2013 | 2467 | 0.020 |
Why?
| | Tibia | 1 | 1989 | 180 | 0.020 |
Why?
| | Regression Analysis | 1 | 2010 | 1010 | 0.020 |
Why?
| | Hindlimb | 1 | 2008 | 133 | 0.020 |
Why?
| | Injections | 1 | 2008 | 187 | 0.020 |
Why?
| | Mesenteric Arteries | 1 | 2007 | 17 | 0.020 |
Why?
| | Celiac Artery | 1 | 2007 | 20 | 0.020 |
Why?
| | Equipment Failure Analysis | 1 | 2007 | 130 | 0.020 |
Why?
| | Femur | 1 | 1989 | 256 | 0.020 |
Why?
| | Contraindications | 1 | 2007 | 87 | 0.020 |
Why?
| | Injury Severity Score | 2 | 2000 | 516 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2008 | 945 | 0.020 |
Why?
| | Weight Loss | 1 | 2011 | 785 | 0.020 |
Why?
| | Retreatment | 1 | 2005 | 71 | 0.010 |
Why?
| | Cartilage, Articular | 1 | 1989 | 330 | 0.010 |
Why?
| | Rats | 1 | 2013 | 5558 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2010 | 1468 | 0.010 |
Why?
| | Neoplasm Metastasis | 1 | 2007 | 670 | 0.010 |
Why?
| | Algorithms | 1 | 2011 | 1701 | 0.010 |
Why?
| | Mice | 1 | 2021 | 17748 | 0.010 |
Why?
| | Child, Preschool | 1 | 2017 | 11102 | 0.010 |
Why?
| | Child | 3 | 2017 | 21833 | 0.010 |
Why?
| | Radiography, Abdominal | 1 | 2001 | 46 | 0.010 |
Why?
| | Blood Flow Velocity | 1 | 2002 | 413 | 0.010 |
Why?
| | Models, Animal | 1 | 2002 | 392 | 0.010 |
Why?
| | Arteriosclerosis | 1 | 2000 | 83 | 0.010 |
Why?
| | Aorta, Abdominal | 1 | 2000 | 46 | 0.010 |
Why?
| | Pneumonia, Aspiration | 1 | 1999 | 17 | 0.010 |
Why?
| | Hematoma | 1 | 1999 | 54 | 0.010 |
Why?
| | Veins | 1 | 1999 | 65 | 0.010 |
Why?
| | Endoscopy | 1 | 2001 | 313 | 0.010 |
Why?
| | Aortic Diseases | 1 | 2000 | 117 | 0.010 |
Why?
| | Esophageal Stenosis | 1 | 1999 | 55 | 0.010 |
Why?
| | Intubation, Gastrointestinal | 1 | 1999 | 77 | 0.010 |
Why?
| | Decision Trees | 1 | 1998 | 87 | 0.010 |
Why?
| | Arm | 1 | 1999 | 107 | 0.010 |
Why?
| | Peripheral Nervous System Diseases | 1 | 1999 | 130 | 0.010 |
Why?
| | Cerebral Infarction | 1 | 1997 | 48 | 0.010 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 1997 | 66 | 0.010 |
Why?
| | Los Angeles | 1 | 1997 | 76 | 0.010 |
Why?
| | Carotid Artery Diseases | 1 | 1997 | 61 | 0.010 |
Why?
| | Neurologic Examination | 1 | 1997 | 125 | 0.010 |
Why?
| | Intracranial Pressure | 1 | 1997 | 58 | 0.010 |
Why?
| | Clinical Protocols | 1 | 1998 | 268 | 0.010 |
Why?
| | Multiple Trauma | 1 | 1997 | 102 | 0.010 |
Why?
| | Enteral Nutrition | 1 | 1999 | 200 | 0.010 |
Why?
| | Glasgow Coma Scale | 1 | 1997 | 194 | 0.010 |
Why?
| | Carotid Stenosis | 1 | 1997 | 95 | 0.010 |
Why?
| | Angioplasty, Balloon | 1 | 1997 | 93 | 0.010 |
Why?
| | Carotid Arteries | 1 | 1997 | 195 | 0.010 |
Why?
| | HIV | 1 | 1997 | 246 | 0.010 |
Why?
| | Heparin | 1 | 1997 | 251 | 0.010 |
Why?
| | DNA, Bacterial | 1 | 1997 | 336 | 0.010 |
Why?
| | Cluster Analysis | 1 | 1997 | 512 | 0.010 |
Why?
| | Synovial Cyst | 1 | 1995 | 3 | 0.010 |
Why?
| | Craniocerebral Trauma | 1 | 1997 | 168 | 0.010 |
Why?
| | DNA, Viral | 1 | 1997 | 368 | 0.010 |
Why?
| | Mycobacterium tuberculosis | 1 | 1997 | 317 | 0.010 |
Why?
| | Brain Ischemia | 1 | 1997 | 343 | 0.010 |
Why?
| | Brain Injuries | 1 | 1997 | 495 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2002 | 5835 | 0.000 |
Why?
| | Tibial Meniscus Injuries | 1 | 1990 | 48 | 0.000 |
Why?
| | Postoperative Period | 1 | 1990 | 347 | 0.000 |
Why?
|
|
Ryu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|